Gery et al [5] showed that PER1 was down-regulated in prostate and colon cancers and played a pro-apoptotic and cancer-suppressive role, while Sato et al [20] demonstrated that PER1 was up-regulated in pancreatic and liver cancers and exerted an anti-apoptotic and cancer-promotive effect. Here, PER1 is linked to cancer.